Niagen Bioscience, Inc. Common Stock
€2.979
EUR
Last updated on --.
24h volume273.46K
24h highest3.0263 EUR
24h lowest2.9412 EUR
24h Price movement+0.73%
NAGE recent prices
24 Hours
+0.73%+€0.0215
30 days
-29.68%-€1.269
60 days
-21.81%-€0.8385
90 days
-32.21%-€1.402
Key data
Previous close2.9584 EUR
Market cap264.39M EUR
Volume273.46K
P/E ratio16.500000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.19780 EUR
Net income (FY)16.03M EUR
Revenue (FY)112.16M EUR
Last report dateMay 6, 2026
About Niagen Bioscience, Inc. Common Stock
HeadquartersLOS ANGELES
Employees (FY)117.00
Revenue per employee (FY)958.61K EUR
Net income per employee (FY)136.99K EUR
Listed onNasdaq
NAGE conversion tables
 |  |
|---|---|
| 0.5 NAGE | 1.489 EUR |
| 1 NAGE | 2.979 EUR |
| 5 NAGE | 14.89 EUR |
| 10 NAGE | 29.79 EUR |
| |
|---|---|
| 0.5 EUR | 0.16779 NAGE |
| 1 EUR | 0.33558 NAGE |
| 5 EUR | 1.677 NAGE |
| 10 EUR | 3.355 NAGE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
NAGE is trading at €2.979, +0.73% over the last 24 hours. Track live moves on the price chart at the top of this page.
The NAGE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. NAGE is currently trading at €2.979, +0.73% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on NAGE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. NAGE's P/E ratio is currently 16.500000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from NAGE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against NAGE's historical range and other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector.
Niagen Bioscience, Inc. Common Stock's market cap is currently 264.39M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume273.46K
24h highest3.0263 EUR
24h lowest2.9412 EUR
24h Price movement+0.73%
Start trade with NAGE Perpetual
Sign up to trade